CAR-T: A patient’s cell therapy success story

January 20, 2021

Clinical trials of (CAR) T-cell therapies can present unprecedented enrolment challenges. How can we encourage participation in these trials? Doug Olson, one of the first CAR-T patients treated on a clinical trial, shares his experiences with Parexel expert, Alberto Grignolo, Corporate Vice President, Regulatory Consulting Services. Visit www.parexel.com/neverstop to learn how our Regulatory & Access experts can help apply patient insights to your strategy.

Previous Video
Maximizing your virtual investigator meeting results
Maximizing your virtual investigator meeting results

Learn how Parexel brings the principles and energy from face-to-face investigator meetings to an interactiv...

Next Video
Parexel on the pulse
Parexel on the pulse

Parexel regulatory expert, Mark Birse, gives an update on BREXIT.